Methimazole
"Methimazole" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A thioureylene antithyroid agent that inhibits the formation of thyroid hormones by interfering with the incorporation of iodine into tyrosyl residues of thyroglobulin. This is done by interfering with the oxidation of iodide ion and iodotyrosyl groups through inhibition of the peroxidase enzyme.
Descriptor ID |
D008713
|
MeSH Number(s) |
D02.886.489.600 D03.383.129.308.535
|
Concept/Terms |
Methimazole- Methimazole
- Mercasolyl
- Mercazolyl
- Merkazolil
- Tiamazol
- Methymazol
- Thiamazole
- Thimazol
- 1-Methyl-2-mercaptoimidazole
- 1 Methyl 2 mercaptoimidazole
- Methylmercaptoimidazole
Tapazole- Tapazole
- Jones Brand of Methimazole
- Eli Lilly Brand of Methimazole
Tirodril- Tirodril
- Estedi Brand of Methimazole
Strumazol- Strumazol
- Nourypharma Brand of Methimazole
Thiamazol Henning- Thiamazol Henning
- Henning, Thiamazol
- Sanofi Synthelabo Brand of Methimazole
- Henning Berlin Brand of Methimazole
Thyrozol- Thyrozol
- Merck Brand of Methimazole
Favistan- Favistan
- Temmler Brand of Methimazole
Methizol- Methizol
- Philopharm Brand of Methimazole
|
Below are MeSH descriptors whose meaning is more general than "Methimazole".
Below are MeSH descriptors whose meaning is more specific than "Methimazole".
This graph shows the total number of publications written about "Methimazole" by people in UAMS Profiles by year, and whether "Methimazole" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2016 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Methimazole" by people in Profiles over the past ten years.
-
Brito JP, Schilz S, Singh Ospina N, Rodriguez-Gutierrez R, Maraka S, Sangaralingham LR, Montori VM. Antithyroid Drugs-The Most Common Treatment for Graves' Disease in the United States: A Nationwide Population-Based Study. Thyroid. 2016 08; 26(8):1144-5.